NEW YORK, NY / ACCESS Newswire / February 2, 2026 / Iron Dome Acquisition I Corp. ("IDAC"), a blank check company ...
Eikon Therapeutics, Inc. ('Eikon”), a late-stage clinical biopharmaceutical company dedicated to developing important, ...
On Jan. 30, 2026, K2 Capital Acquisition Corporation (NASDAQ:KTWOU) (the "Company") announced the closing of its upsized ...
Agomab Therapeutics NV (Nasdaq: AGMB) ('Agomab”), a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an ...
Foraker and Garner got involved with Once Upon a Time after discovering the baby food brand launched by Cassandra Curtis and Ari Raz. The brand's focus on fresh and organic ingredients appealed to ...
Veradermics Inc., a late clinical-stage biopharmaceutical company focused on hair restoration, raised $256.3 million in an ...
Learn how to evaluate new IPOs, understand valuation methods, and decide if you should invest. Key questions can help you assess potential stocks.
NEW YORK, NY / ACCESS Newswire / January 29, 2026 / On January 28, 2026, GigCapital9 Corp. closed its Initial Public ...
Helix Acquisition Corp. III (Nasdaq: HLXC) (the “Company”) announced today that on January 26, 2026, it closed the initial public offering of 17,250,000 Class A ordinary shares, which includes ...
SpyGlass Pharma, Inc. (Nasdaq: SGP) ("SpyGlass Pharma"), a late-stage biopharmaceutical company, today announced the pricing of its initial public ...
Irish Examiner on MSN
Elon Musk combines firms SpaceX and xAI ahead of expected public offering later this year
The world’s richest man Elon Musk is combining his companies SpaceX and xAI in a deal that values the enlarged entity at ...
TYSONS CORNER, Va.--(BUSINESS WIRE)-- Strategy Inc (MSTR) today announced that, subject to market and other conditions, it intends to conduct an initial public offering registered under the Securities ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results